Uterine Artery Embolization (UAE)

PROCEDURE3 trials

Sponsors

Mayo Clinic, Acessa Health, Inc.

Conditions

FibroidsMyomasSymptomatic Uterine FibroidsSymptomatic Uterine LeiomyomasUterine Fibroids

Phase 4

The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.

CompletedNCT00995878

Mayo ClinicFibroids, Myomas, Symptomatic Uterine Leiomyomas +1

Start: 2010-04-29End: 2017-12-31Updated: 2018-01-12

Unknown Phase

Post Market TRUST Study

CompletedNCT01563783

Acessa Health, Inc.Uterine Fibroids

Start: 2012-12-31End: 2022-06-30Updated: 2023-02-01

Post Market TRUST - U.S.A. Study

CompletedNCT02163525

Acessa Health, Inc.Symptomatic Uterine Fibroids

Start: 2014-06-12End: 2025-09-12Updated: 2025-09-30

Related Papers

Uterine and Fibroid Imaging Analysis from the FIRSTT Study

Journal of Women s Health2021-07-099 citations

FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery

American Journal of Obstetrics and Gynecology2018-10-2683 citations

Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial.

2016-04-0914 citations

Effect of menses on standardized assessment of sexual dysfunction among women with uterine fibroids: a cohort study.

2015-05-166 citations

Comparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: reducing symptoms today and tomorrow (FIRSTT) trial.

2011-07-2727 citations